BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22418245)

  • 21. Prognostic value of epidermal growth factor receptor gene mutation in resected lung adenocarcinoma.
    Deng C; Zhang Y; Ma Z; Fu F; Deng L; Li Y; Chen H
    J Thorac Cardiovasc Surg; 2021 Sep; 162(3):664-674.e7. PubMed ID: 32747123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Unique microRNAs in lung adenocarcinoma groups according to major TKI sensitive EGFR mutation status.
    Pak MG; Lee CH; Lee WJ; Shin DH; Roh MS
    Diagn Pathol; 2015 Jul; 10():99. PubMed ID: 26170125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic analysis of primary mucin-producing adenocarcinoma of the lung: a comprehensive retrospective study.
    Qu Y; Zhao D; Mu J; Che N; Zhang C; Liu Z; Su D; Zhou L; Zhang H; Wei L
    Tumour Biol; 2016 Jan; 37(1):887-96. PubMed ID: 26254613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of thyroid transcription factor-1 in advanced lung adenocarcinoma under epidermal growth factor receptor tyrosine kinase inhibitor treatment.
    Chung KP; Huang YT; Chang YL; Yu CJ; Yang CH; Chang YC; Shih JY; Yang PC
    Chest; 2012 Feb; 141(2):420-428. PubMed ID: 21799026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lung Adenocarcinoma With MUC4 Expression Is Associated With Smoking Status, HER2 Protein Expression, and Poor Prognosis: Clinicopathologic Analysis of 338 Cases.
    Rokutan-Kurata M; Yoshizawa A; Sumiyoshi S; Sonobe M; Menju T; Momose M; Koyama M; Shigeto S; Fujimoto M; Zhang M; Morita S; Date H; Haga H
    Clin Lung Cancer; 2017 Jul; 18(4):e273-e281. PubMed ID: 28065467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TTF-1 and napsin A do not differentiate metastatic lung adenocarcinomas from primary esophageal adenocarcinomas: proposal of a novel staining panel.
    Aulakh KS; Chisholm CD; Smith DA; Speights VO
    Arch Pathol Lab Med; 2013 Aug; 137(8):1094-8. PubMed ID: 23899066
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Combined detection of thyroid transcription factor 1 and napsin A in pleural fluid cell blocks facilitates cytopathologic diagnosis of pulmonary adenocarcinoma].
    Xu X; Liu H; Jiang H; Li C; Yuan S; Yang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1610-3. PubMed ID: 26607085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.
    Kadivar M; Boozari B
    Appl Immunohistochem Mol Morphol; 2013 May; 21(3):191-5. PubMed ID: 22914608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis and comparison of napsin A, TTF1, SPA and CK7 expression in primary lung adenocarcinoma.
    Jin L; Liu Y; Wang X; Qi X
    Biotech Histochem; 2018; 93(5):364-372. PubMed ID: 29956575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Best immunohistochemical panel in distinguishing adenocarcinoma from squamous cell carcinoma of lung: tissue microarray assay in resected lung cancer specimens.
    Kim MJ; Shin HC; Shin KC; Ro JY
    Ann Diagn Pathol; 2013 Feb; 17(1):85-90. PubMed ID: 23040737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of Napsin A and Survivin Immunohistochemical Expression in Bronchogenic Adenocarcinoma.
    Mohammed Salama ME
    Asian Pac J Cancer Prev; 2020 Nov; 21(11):3345-3348. PubMed ID: 33247694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological and Prognostic Significance of the EML4-ALK Translocation and IGFR1, TTF1, Napsin A Expression in Patients with Lung Adenocarcinoma.
    Bulutay P; AkyÜrek N; MemiŞ L
    Turk Patoloji Derg; 2021; 37(1):7-17. PubMed ID: 32876329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary lung adenocarcinoma with morule-like components: a unique histologic hallmark of aggressive behavior and EGFR mutation.
    Tsuta K; Kawago M; Yoshida A; Sekine S; Asamura H; Furuta K; Kushima R
    Lung Cancer; 2014 Jul; 85(1):12-8. PubMed ID: 24768118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Correlation of caveolin-1 expression with clinicopathologic features and prognosis in patients with lung adenocarcinoma].
    Wang Y; Liu B; Xu Y; Zhang J; Xia Q; Yu B; Zhang R; Shi S; Lu Z; Zhou X
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):251-5. PubMed ID: 24915816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MET gene copy number gain is an independent poor prognostic marker in Korean stage I lung adenocarcinomas.
    Jin Y; Sun PL; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
    Ann Surg Oncol; 2014 Feb; 21(2):621-8. PubMed ID: 24212721
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype.
    Warth A; Penzel R; Lindenmaier H; Brandt R; Stenzinger A; Herpel E; Goeppert B; Thomas M; Herth FJ; Dienemann H; Schnabel PA; Schirmacher P; Hoffmann H; Muley T; Weichert W
    Eur Respir J; 2014 Mar; 43(3):872-83. PubMed ID: 23988776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
    Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
    Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The utility of TTF-1, napsin A, CK5 and p63 staining in the sub-classification of non-small cell carcinoma of the lung.
    van Zyl A; Schubert PT; Koegelenberg CFN
    Cytopathology; 2019 Nov; 30(6):586-591. PubMed ID: 31206846
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
    Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
    Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil.
    de Melo AC; Karen de Sá V; Sternberg C; Olivieri ER; Werneck da Cunha I; Fabro AT; Carraro DM; de Barros e Silva MJ; Pimenta Inada HK; de Mello ES; Soares FA; Takagaki T; Ferreira CG; Capelozzi VL
    Oncology; 2015; 89(3):175-86. PubMed ID: 25833149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.